APO RESEARCH · REPORT
Codeine Phosphate
Codeine phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions.
Product & engineering
Understand the product.
Codeine phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions.
Selected research
Market Outlook & Growth Opportunities
Global Codeine Phosphate Market Outlook and Growth Opportunities 2026
Market perspective
Codeine phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions.
Global Codeine Phosphate key players include Macfarian Smith, Francopia, Noramco, etc. Global top three manufacturers hold a share over 40%.
Europe is the largest market, with a share about 30%, followed by East & South Asia, and North America, both have a share over 35 percent.
Read the full market overview
In terms of product, Extracted from Opium is the largest segment, with a share over 60%. And in terms of application, the largest application is Antitussive, followed by Narcotic Analgesic, etc.
This report provides an overview of the global Codeine Phosphate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Codeine Phosphate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Codeine Phosphate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Codeine Phosphate market size, projected growth trends, production technologies, key applications, and end-use industries.
Codeine Phosphate Segment by Company
Macfarian Smith
Francopia
Noramco
Weifa
Mallinckrodt
Temad
GSK
Alkaloida
Tas. Alkaloids
Alcaliber
Fine Chemicals
Aesica
Sino Pharm
Sri Krishna
TPI
Codeine Phosphate Segment by Type
Extracted from Opium
Synthesized by Morphine
Codeine Phosphate Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Phosphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Codeine Phosphate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Codeine Phosphate market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Codeine Phosphate significant trends, drivers, influence factors in global and regions.
6. To analyze Codeine Phosphate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Phosphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Phosphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Phosphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Codeine Phosphate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine Phosphate industry.
Chapter 3: Detailed analysis of Codeine Phosphate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Codeine Phosphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Codeine Phosphate in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Extracted from Opium
- Synthesized by Morphine
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- Macfarian Smith
- Francopia
- Noramco
- Weifa
- Mallinckrodt
- Temad
- GSK
- Alkaloida
- Tas. Alkaloids
- Alcaliber
- Fine Chemicals
- Aesica
- Sino Pharm
- Sri Krishna
- TPI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Codeine Phosphate Sales Value (2021-2032)
- 1.2.2 Global Codeine Phosphate Sales Volume (2021-2032)
- 1.2.3 Global Codeine Phosphate Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Codeine Phosphate Market Dynamics
- 2.1 Codeine Phosphate Industry Trends
- 2.2 Codeine Phosphate Industry Drivers
- 2.3 Codeine Phosphate Industry Opportunities and Challenges
- 2.4 Codeine Phosphate Industry Restraints
3 Codeine Phosphate Market by Company
- 3.1 Global Codeine Phosphate Company Revenue Ranking in 2025
- 3.2 Global Codeine Phosphate Revenue by Company (2021-2026)
- 3.3 Global Codeine Phosphate Sales Volume by Company (2021-2026)
- 3.4 Global Codeine Phosphate Average Price by Company (2021-2026)
- 3.5 Global Codeine Phosphate Company Ranking (2024-2026)
- 3.6 Global Codeine Phosphate Company Manufacturing Base and Headquarters
- 3.7 Global Codeine Phosphate Company Product Type and Application
- 3.8 Global Codeine Phosphate Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Codeine Phosphate Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Codeine Phosphate Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Codeine Phosphate Market by Type
- 4.1 Codeine Phosphate Type Introduction
- 4.1.1 Extracted from Opium
- 4.1.2 Synthesized by Morphine
- 4.2 Global Codeine Phosphate Sales Volume by Type
- 4.2.1 Global Codeine Phosphate Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Codeine Phosphate Sales Volume by Type (2021-2032)
- 4.2.3 Global Codeine Phosphate Sales Volume Share by Type (2021-2032)
- 4.3 Global Codeine Phosphate Sales Value by Type
- 4.3.1 Global Codeine Phosphate Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Codeine Phosphate Sales Value by Type (2021-2032)
- 4.3.3 Global Codeine Phosphate Sales Value Share by Type (2021-2032)
5 Codeine Phosphate Market by Application
- 5.1 Codeine Phosphate Application Introduction
- 5.1.1 Narcotic Analgesic
- 5.1.2 Antitussive
- 5.1.3 Others
- 5.2 Global Codeine Phosphate Sales Volume by Application
- 5.2.1 Global Codeine Phosphate Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Codeine Phosphate Sales Volume by Application (2021-2032)
- 5.2.3 Global Codeine Phosphate Sales Volume Share by Application (2021-2032)
- 5.3 Global Codeine Phosphate Sales Value by Application
- 5.3.1 Global Codeine Phosphate Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Codeine Phosphate Sales Value by Application (2021-2032)
- 5.3.3 Global Codeine Phosphate Sales Value Share by Application (2021-2032)
6 Codeine Phosphate Regional Sales and Value Analysis
- 6.1 Global Codeine Phosphate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Codeine Phosphate Sales by Region (2021-2032)
- 6.2.1 Global Codeine Phosphate Sales by Region: 2021-2026
- 6.2.2 Global Codeine Phosphate Sales by Region (2027-2032)
- 6.3 Global Codeine Phosphate Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Codeine Phosphate Sales Value by Region (2021-2032)
- 6.4.1 Global Codeine Phosphate Sales Value by Region: 2021-2026
- 6.4.2 Global Codeine Phosphate Sales Value by Region (2027-2032)
- 6.5 Global Codeine Phosphate Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Codeine Phosphate Sales Value (2021-2032)
- 6.6.2 North America Codeine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Codeine Phosphate Sales Value (2021-2032)
- 6.7.2 Europe Codeine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Codeine Phosphate Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Codeine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Codeine Phosphate Sales Value (2021-2032)
- 6.9.2 South America Codeine Phosphate Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Codeine Phosphate Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Codeine Phosphate Sales Value Share by Country, 2025 VS 2032
7 Codeine Phosphate Country-level Sales and Value Analysis
- 7.1 Global Codeine Phosphate Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Codeine Phosphate Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Codeine Phosphate Sales by Country (2021-2032)
- 7.3.1 Global Codeine Phosphate Sales by Country (2021-2026)
- 7.3.2 Global Codeine Phosphate Sales by Country (2027-2032)
- 7.4 Global Codeine Phosphate Sales Value by Country (2021-2032)
- 7.4.1 Global Codeine Phosphate Sales Value by Country (2021-2026)
- 7.4.2 Global Codeine Phosphate Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.9.2 France Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.16.2 China Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.19.2 India Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Codeine Phosphate Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Codeine Phosphate Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Codeine Phosphate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Macfarian Smith
- 8.1.1 Macfarian Smith Company Information
- 8.1.2 Macfarian Smith Business Overview
- 8.1.3 Macfarian Smith Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Macfarian Smith Codeine Phosphate Product Portfolio
- 8.1.5 Macfarian Smith Recent Developments
- 8.2 Francopia
- 8.2.1 Francopia Company Information
- 8.2.2 Francopia Business Overview
- 8.2.3 Francopia Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Francopia Codeine Phosphate Product Portfolio
- 8.2.5 Francopia Recent Developments
- 8.3 Noramco
- 8.3.1 Noramco Company Information
- 8.3.2 Noramco Business Overview
- 8.3.3 Noramco Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Noramco Codeine Phosphate Product Portfolio
- 8.3.5 Noramco Recent Developments
- 8.4 Weifa
- 8.4.1 Weifa Company Information
- 8.4.2 Weifa Business Overview
- 8.4.3 Weifa Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Weifa Codeine Phosphate Product Portfolio
- 8.4.5 Weifa Recent Developments
- 8.5 Mallinckrodt
- 8.5.1 Mallinckrodt Company Information
- 8.5.2 Mallinckrodt Business Overview
- 8.5.3 Mallinckrodt Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Mallinckrodt Codeine Phosphate Product Portfolio
- 8.5.5 Mallinckrodt Recent Developments
- 8.6 Temad
- 8.6.1 Temad Company Information
- 8.6.2 Temad Business Overview
- 8.6.3 Temad Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Temad Codeine Phosphate Product Portfolio
- 8.6.5 Temad Recent Developments
- 8.7 GSK
- 8.7.1 GSK Company Information
- 8.7.2 GSK Business Overview
- 8.7.3 GSK Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.7.4 GSK Codeine Phosphate Product Portfolio
- 8.7.5 GSK Recent Developments
- 8.8 Alkaloida
- 8.8.1 Alkaloida Company Information
- 8.8.2 Alkaloida Business Overview
- 8.8.3 Alkaloida Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Alkaloida Codeine Phosphate Product Portfolio
- 8.8.5 Alkaloida Recent Developments
- 8.9 Tas. Alkaloids
- 8.9.1 Tas. Alkaloids Company Information
- 8.9.2 Tas. Alkaloids Business Overview
- 8.9.3 Tas. Alkaloids Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Tas. Alkaloids Codeine Phosphate Product Portfolio
- 8.9.5 Tas. Alkaloids Recent Developments
- 8.10 Alcaliber
- 8.10.1 Alcaliber Company Information
- 8.10.2 Alcaliber Business Overview
- 8.10.3 Alcaliber Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Alcaliber Codeine Phosphate Product Portfolio
- 8.10.5 Alcaliber Recent Developments
- 8.11 Fine Chemicals
- 8.11.1 Fine Chemicals Company Information
- 8.11.2 Fine Chemicals Business Overview
- 8.11.3 Fine Chemicals Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Fine Chemicals Codeine Phosphate Product Portfolio
- 8.11.5 Fine Chemicals Recent Developments
- 8.12 Aesica
- 8.12.1 Aesica Company Information
- 8.12.2 Aesica Business Overview
- 8.12.3 Aesica Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Aesica Codeine Phosphate Product Portfolio
- 8.12.5 Aesica Recent Developments
- 8.13 Sino Pharm
- 8.13.1 Sino Pharm Company Information
- 8.13.2 Sino Pharm Business Overview
- 8.13.3 Sino Pharm Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Sino Pharm Codeine Phosphate Product Portfolio
- 8.13.5 Sino Pharm Recent Developments
- 8.14 Sri Krishna
- 8.14.1 Sri Krishna Company Information
- 8.14.2 Sri Krishna Business Overview
- 8.14.3 Sri Krishna Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Sri Krishna Codeine Phosphate Product Portfolio
- 8.14.5 Sri Krishna Recent Developments
- 8.15 TPI
- 8.15.1 TPI Company Information
- 8.15.2 TPI Business Overview
- 8.15.3 TPI Codeine Phosphate Sales, Value and Gross Margin (2021-2026)
- 8.15.4 TPI Codeine Phosphate Product Portfolio
- 8.15.5 TPI Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Codeine Phosphate Value Chain Analysis
- 9.1.1 Codeine Phosphate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Codeine Phosphate Sales Mode & Process
- 9.2 Codeine Phosphate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Codeine Phosphate Distributors
- 9.2.3 Codeine Phosphate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst